SKEL has signed purchase agreements with a group of domestic institutional investors for their acquisition of 153.9 million shares in Styrkás hf., representing just over 15.4% of the company’s issued share capital. The total purchase price of the shares is ISK 3,150 million, equivalent to ISK 20.47 per share. The sale price is equal to the book value of SKEL’s stake in Styrkás as of December 31, 2024. The purchase agreements are subject to customary conditions, which are expected to be finalized next week. ...

Financial Data and Key Metrics Changes - The company generated net sales of $116 million in Q1 2025, a decrease of 14% compared to $135 million in Q1 2024 [6][18] - Adjusted EBITDA for Q1 2025 was $3 million, down from $15.5 million in the same period last year [6][18] - Operating expenses decreased by $5 million year-over-year, and net trade working capital was reduced by $86 million [5][11] Business Line Data and Key Metrics Changes - Metem sales increased by 14% year-over-year, while Diamond sales rose by 17% due to increased peanut acreage [9][10] - The absence of a previously canceled herbicide product negatively impacted sales, alongside weakness in the Mexican agave market and drought conditions in Australia [9][18] Market Data and Key Metrics Changes - Inventory levels at distributors are down nearly 23% compared to the previous year, indicating a prolonged destocking period [25] - Corn plantings are at historically high levels, which is expected to positively impact demand for crop protection products [25] Company Strategy and Development Direction - The company is focused on cost containment and improving net working capital, with a goal of achieving a 15% adjusted EBITDA margin over the cycle [11][27] - A transformation plan is in place to streamline operations and improve financial results, with expectations of a cyclical recovery in the agricultural market [24][27] Management's Comments on Operating Environment and Future Outlook - Management noted that while the first quarter was weaker than anticipated, there are signs of recovery as customer activity levels are beginning to pick up [24][62] - The company has adjusted its full-year adjusted EBITDA target range to $40 million to $44 million, down from $45 million to $52 million, reflecting a cautious outlook [13][23] Other Important Information - The company faced delays in filing its 10-K and 10-Q due to internal control matters and the need for a detailed review of major assets [14][16] - The current credit agreement matures in Q3 2026, and the company is exploring options for a longer-term capital structure [21][22] Q&A Session Summary Question: Can you elaborate on the year-over-year top line performance? - Management indicated that the destocking period continued into Q1 2025, affecting sales, but positive trends were observed in May and June [30][34] Question: What were the EBITDA and revenue contributions from Dactol? - Dactol contributed $6 million to top line sales with a gross margin of 13.5% [36][37] Question: What are the expectations for cash taxes this year? - Cash taxes are expected to be in the range of $4 million to $5 million due to international obligations [44] Question: How does the company view the competitive pricing environment? - Management noted unusual competitive activity in Q1, leading to discounting, but expects improvements in pricing as demand increases [58][59]

CVR Partners (NYSE: UAN ) is a limited partnership that covers the supply chain of nitrogen fertilizer products. It operates as a growth company in the agricultural chemicals industry with products such as ammonium nitrate and general ammonia. These areAs a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a particular interest in sectors such as Oi ...

June 6, 2025 12:19 AM GMT Novonesis | Europe Unpacking The Debate Further The key debate and pushback we got from our Overweight initiation centered around mid-term growth expectations and NSISB's sensitivity to oil price volatility. In contrast, we see the combination of structural growth drivers, NSISBs unique offering and operational gearing as basis to defuse concerns Overweight thesis intact, PT DKK577 - We initiated coverage of Novonesis last week at Overweight. Our deep-dive analysis of key end marke ...

Rotterdam, The Netherlands (6 June 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in Ferrer Alimentación, S.A. and Medir Ferrer Y Compañía, S.A. (jointly “Ferrer Alimentación”). Founded in 1955, Ferrer Alimentación is a leading distributor in Iberia of food and beverage ingredients. Ferrer Alimentación is well established and recognised for its strong presenc ...

Dow (NYSE: DOW ) has been paying dividends continuously since 1912 and today it’s yielding nearly 10%. That’s no coincidence. In a stock market full of pessimism, geopolitical tensions, and demand shortages, Dow stands out as a dividend giant in dire straits. I was intriguedI'm a passionate investor from the Netherlands with 12 years of stock market experience. My articles usually contain a good overview of important investment criteria. A stock for my portfolio is of interest to me if the company has the f ...

Eastman Chemical Company (EMN) FY Conference June 05, 2025 12:30 PM ET Speaker0 Maybe I'll jump a little bit to the segment level, if that's okay, and we can hit those at a high level. Our Additives and Functional Products business, we said would be moderately down sequentially on the Q1 call. With the pause in the tariffs and also the stable end markets, we actually see our Additives and Functional Products performing well and expect that it will actually be similar, if not a little better compared to Q1. ...

Company Overview - Perimeter Solutions, SA (PRM) currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy) [3][4] - The company has shown strong price performance, with shares up 30.46% over the past three months and 63.33% over the last year [7] Price Performance - Over the past week, PRM shares increased by 2.9%, outperforming the Zacks Chemical - Specialty industry, which rose by 1.03% [6] - The monthly price change for PRM is 19.51%, significantly higher than the industry's 4.62% [6] Trading Volume - PRM's average 20-day trading volume is 1,019,817 shares, indicating a bullish trend when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for PRM has moved higher, increasing the consensus estimate from $0.68 to $1.14 [10] - For the next fiscal year, one estimate has also moved upwards, with no downward revisions during the same period [10]

Celanese (CE) FY Conference June 05, 2025 11:50 AM ET Speaker0 Thank you and good morning. My name is Dave Begleiter of the U. S. Pembos team here at Deutsche Bank. Next up is the team from Celanese led by Scott Richardson. Scott became CEO January first. He spent over twenty years at Celanese in various roles in Asia and U. S. Driving value and outcomes. So a lot of happiness in Celanese the last couple of years. We'll have Scott make a few brief comments around where they are today. We'll go into the fire ...

Company Overview - Cabot (CBT) shares have increased by approximately 3.9% over the past month, underperforming the S&P 500 index [1] - The most recent earnings report is crucial for understanding the key drivers affecting the stock [1] Earnings Estimates - Estimates for Cabot have trended downward in the past month, with a consensus estimate shift of -6.59% [2] - The overall direction of estimate revisions indicates a negative outlook for the stock [4] VGM Scores - Cabot has a Growth Score of B, but a low Momentum Score of F, while achieving an A grade in value, placing it in the top 20% for this investment strategy [3] - The aggregate VGM Score for Cabot is B, which is relevant for investors not focused on a single strategy [3] Industry Performance - Cabot is part of the Zacks Chemical - Diversified industry, where another player, Air Products and Chemicals (APD), has seen a 5.9% gain over the past month [5] - Air Products and Chemicals reported revenues of $2.92 billion for the last quarter, reflecting a year-over-year decline of -0.5% [5] - The expected earnings for Air Products and Chemicals for the current quarter is $2.97 per share, indicating a -7.2% change from the previous year [6]